Dr. Philibert completed his MD PhD and Psychiatry training at the University of Iowa.  Subsequently, he completed six years of fellowship at the National Institutes of Health, then returned to Iowa, where he maintains a part-time appointments in Psychiatry, Genetics, Molecular Medicine, Neuroscience and Biomedical Engineering, as well as a busy research lab.  He has over 220 peer reviewed publications, numerous patents and grants, and has founded or co-founded three companies, including Cardio Diagnostics, which listed on NASDAQ in 2022, and Behavioral Diagnostics, which is the emerging leader of epigenetic tools for  cancer prevention, mortality risk and wellness products for the life insurance industry.

A full 17 page CV is available upon request.